Cited by 557Coenzyme Q10 studies and effectsMitochondrial Function and PathologyNeuroprotection in Cerebral Ischemia

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Coenzyme Q 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects

Open access

Matthews, Russell T., Yang, Lichuan, Browne, Susan, Baik, Myong, Beal, M. Flint·1998·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.95.15.8892PMC PMC21173

Open this paper in CoChat — free account

Abstract

Coenzyme Q 10 is an essential cofactor of the electron transport chain as well as a potent free radical scavenger in lipid and mitochondrial membranes. Feeding with coenzyme Q 10 increased cerebral cortex concentrations in 12- and 24-month-old rats. In 12-month-old rats administration of coenzyme Q 10 resulted in significant increases in cerebral cortex mitochondrial concentrations of coenzyme Q 10 . Oral administration of coenzyme Q 10 markedly attenuated striatal lesions produced by systemic administration of 3-nitropropionic acid and significantly increased life span in a transgenic mouse model of familial amyotrophic lateral sclerosis. These results show that oral administration of coenzyme Q 10 increases both brain and brain mitochondrial concentrations. They provide further evidence that coenzyme Q 10 can exert neuroprotective effects that might be useful in the treatment of neurodegenerative diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.95.15.8892

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
Wong, P. C., Pardo, C. A., Borchelt, D., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,439
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434
Self-citation
ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Biochemical, physiological and medical aspects of ubiquinone function
Ernster, L., & Dallner, G. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00028-3 · Cited by 1,246
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962
Self-citation
Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis
Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., & Hall, E. D. (1996) · Annals of Neurology · doi:10.1002/ana.410390203 · Cited by 647
Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.
Frei, B. B., Kim, M. C., & Ames, B. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4879 · Cited by 623
Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease
Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531
Self-citation

Show all 49 references

Research works printed but not linked: 6

S Sugiyama, K Yamada, T Ozawa Biochem Mol Biol Int 37, 1111–1120 (1995).
A Sanbe, K Tanonaka, Y Niwano, S Takeo J Pharmacol Exp Ther 269, 51–56 (1994).
S Takeo, K Tanonaka, T Tazuma, K Miyake, R Murai J Pharmacol Exp Ther 243, 1131–1138 (1987).
T Nakamura, H Sanma, M Himeno, K Kato Transfer of Exogenous Coenzyme Q to Inner Membrane of Heart Mitochondria in Rats, eds Y Yamamura, K Folkers, Y Ito (Elsevier, Amsterdam) 2, 3–11 (1989).
V Valls, C Castelluccio, R Fato, M L Genova, C Bovina, G Saez, M Marchetti, P Castelli, G Lenaz Biochem Mol Biol Int 33, 633–642 (1994).
S Reahal, J Wrigglesworth Drug Metab Dispos 20, 423–427 (1992).

Sorted by citations

Items 501–556 of 556

Potential Therapies for Mitochondrial Dysfunction
Henchcliffe, C., & Beal, M. F. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_13 · Cited by 1
Self-citation
Chapter 19 Therapies in amyotrophic lateral sclerosis: Options for the near and far future
Lemmens, R., Bosch, L. V. D., & Robberecht, W. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)80022-4 · Cited by 1
Chapter 11 Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
(2003) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70112-6 · Cited by 1
Chapter 7 Current and Future Prospects for the Treatment of Mitochondrial Disorders
Taylor, R. W., & Turnbull, D. M. (2002) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70066-2 · Cited by 1
Inhibition of monoamine oxidase by selected 8–[(phenylsulfanyl)methyl]caffeine derivatives
Okaecwe, T. A. D. (2012) · Cited by 1
Pharmacologic Management of Parkinson Disease: Choice of Initial Therapy in Early Disease
Chen, J. J., & Pahwa, R. (2008) · Journal of Pharmacy Practice · doi:10.1177/0897190008318129 · Cited by 1
Identifying new therapeutics for Huntington's disease
Schilling, G., & Borchelt, D. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00060-4 · Cited by 1
A Gain of Function of the Huntington’s Disease and Amyotrophic Lateral Sclerosis-Associated Genetic Mutations May Be a Loss of Bioenergetics
Beal, M. F. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_13 · Cited by 1
Self-citation
N EL R EVIEW The role of metals in autoimmunity and the link to neuroendocrinology
Stejskal, J., & Stejskal, V. D. M. (1999) · Cited by 1
Nutritional Deficiency and its Modulation in Old Age
Ferrari, C. K. B. (2007) · Springer eBooks · doi:10.1007/1-4020-5058-5_16 · Cited by 1
Advances in Neuroprotection Research for Neurodegenerative Diseases
Götz, M. E., & Riederer, P. F. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8969-7_1 · Cited by 1
Mitochondrial Membrane Permeabilization in Physiological and Pathological Cell Death
Ravagnan, L., & Kroemer, G. (2001) · Research and perspectives in neurosciences · doi:10.1007/978-3-662-04333-2_2
Metabolic Regulation of Endothelial Dysfunction and Cardiovascular Risk
Young, J. M. (2012) · Otago University Research Archive (University of Otago)
Effect of mitochondrially targeted vitamin E on oxidative stress and obesity development in C57BL/6 mice
Mao, G. (2009) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-1827
Chapter 11 Metabolic Causes of Ataxia
Schapira, A. H. V. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70085-1
(3)抗酸化作用( バイオファクタ研究のブレークスルー : 「ユビキノン(コエンザイムQ)」)
山本, 順. (2001) · ビタミン · doi:10.20632/vso.75.5-6_279
Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders
Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306
Self-citation
NUTRITIONAL DEFICIENCY AND ITS MODULATION IN OLD AGE
Chico, R. P. (2006)
A Comparative study of iodine value and acid value of Fresh and Used Sunflower oils
Joseph, B., Paul, M., Babu, I., & Reshma, P. (2013)
The Role of the Plasma Membrane Redox System in the Pathogenesis of Alzheimer’s Disease
Hancock, S. M., Finkelstein, D. I., Bush, A. I., & Adlard, P. A. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-62703-598-9_6
SHILAJIT DIBEZOαPYROES: MITOCHODRIA TARGETED ATIOXIDATS
Bhattacharyya, S., Pal, D., Banerjee, D., Auddy, B., Ganguly, P., Majumder, U. K., & Ghosal, S. (2009)
Wirkung von Hemmstoffen und Antioxidantien in Gliazellen bei Anoxie/Reoxygenierung und in der hepatischen Enzephalopathie
Widmer, R. (2007) · doi:10.14279/depositonce-1542
Mitochondria, metabolic inhibitors and neurodegeneration
Greene, J. G., & Greenamyre, J. T. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.004
Intervencion dietoterapéutica en la citopatía mitocondrial. A propósito de un caso
Romo, M. C., Plasencia, L. M. M., Santana, M. B. P., Ortega, A. S., Rodríguez, C. P., & Riverí, M. C. (2012) · Revista Cubana de Alimentación y Nutrición
Koenzym Q10 beim Morbus Parkinson : Symptomatische oder neuroprotektive Effekte?
Storch, A. (2007) · Der Nervenarzt
Molecular Theories of Aging and Nutritional Interventions
Armbrecht, H. J. (2007) · Nutrition and disease prevention · doi:10.1201/9781420005493.ch2
The Neuroprotective Role of Micronutrients in Parkinson’s Disease
Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · doi:10.1201/9781420073522-7
Current and potential therapeutics in motor neuron diseases
Wood-Allum, C. A., & Shaw, P. J. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.053
Industrial Production of Nanonutraceuticals
Rajendran, K., & Sen, S. (2016) · Nutraceuticals · doi:10.1201/9781315370859-15
Is mitochondrial oxidative metabolism the right therapy target in early Huntington disease?
Lodi, R. (2016) · Neurology · doi:10.1212/wnl.0000000000003497
Natural Neuroprotectives for the Management of Parkinson's Disease
Gaba, B., Kumar, S., Md, S., Baboota, S., Narang, J. K., & Ali, J. (2017) · Wiley eBooks · doi:10.1002/9783527803781.ch4
MALATTIA DI HUNTINGTON AD ESORDIO TARDIVO: ENTITA' CLINICA DISTINTA?
Mariani, C. B., Della, D., & Weinstein, R. (2015)
The effects of ubiquinone antioxidants on the MCL1 gene in the CA1 pyramidal cells of hippocampus of male Wistar rat following transient reperfusion inclusive ischemia
Shahenayati, M. S., & Entezari, M. (2018) · فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران · doi:10.29252/iau.28.4.270
Cell replacement therapy for Huntington's disease : what we have learned from post-mortem analyses of grafted patients and mice models
Cisbani, G. (2014)
Axon pathology in mouse models of Huntington's disease
Marangoni, M. (2014) · Nottingham ePrints (University of Nottingham)
Amyotrophic Lateral Sclerosis and Related Motor Neuron Disorders
Brown, R. H. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_115
Redox nanoparticles
Obulesu, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819882-7.00006-4
Structure: From Organelle and Cell Membrane to Tissue
Musnick, D., Severson, L., & Brennan, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-30730-1_12
Митохондрии клеток церебрального эндотелия как потенциальная мишень для нейропротекторного действия коэнзима Q10
Шаповал, Н. С., Os, M., Васильевич, М. А., Константиновна, А. С., & Салмина, А. Б. (2020) · Экспериментальная и клиническая фармакология · doi:10.30906/0869-2092-2020-83-3-40-46
Medical treatment of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00006-8
Future Priorities and Directions in ALS Research and Treatment
Morrice, J. R., Kuo, M., & Shaw, C. A. (2021) · Wiley eBooks · doi:10.1002/9781119745532.ch10
Parkinson Disease
Simmons, A. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00013-3
The Neuroprotective Role of Micronutrients in Parkinson’s Disease
Tsika, E., Ischiropoulos, H., & Malkus, K. A. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch2
Strategies for improving hydration in patients with amyotrophic lateral sclerosis/motor neuron disease
Oda, A. L., & Salvioni, C. C. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00029-5
Coenzyme Q10: Does it benefit neurological diseases?
Chen, T. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3012862
Mitochondrien und Orthomolekularmedizin: neue Perspektiven in der Behandlung des Fibromyalgie-Syndroms
Bulasikis, C. (2024) · Erfahrungsheilkunde · doi:10.1055/a-2257-6706
The pathophysiology of neurodegenerative diseases: The back effects of oxidative stress and antioxidants system
Bikri, S., Aboussaleh, Y., & Fouad, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00011-7
Direct Quantification of Neuroprotective Effect of Single‐Atom Catalyst on Neurochemical Transmission by Multi‐Spatiotemporal Electrochemistry
Ma, W., Zhao, G., Liu, R., Li, K., Wu, W., Liu, J., He, X., Hou, L., Yu, P., & Mao, L. (2025) · Angewandte Chemie · doi:10.1002/ange.202502163
Migraine sufferers have treatment choices – a neurologist explains options beyond just pain medication
Wilhour, D. (2022) · doi:10.64628/aai.fp7wpdyv6
The Neuroprotective Efficacy of Antioxidants Against In Vitro Models of Oxidative Stress and Their Theoretical Application Via Intravitreal Injection Encapsulated in Nanoparticles
Heck, A. J. (2010) · Digital Commons @ UNT Health Science Center
Melissa phospholipids improves sleep quality and mental well-being: concluding results from clinical study in adults with emotional distress
Rondanelli, M., Mazzola, G., Barrile, G. C., Misiano, P., & Perna, S. (2026) · Food & Nutrition Research · doi:10.29219/fnr.v70.13729
Bio-inspired spatiotemporal cascade reaction liposome for ferroptosis treatment following subarachnoid hemorrhage
Peng, Z., Li, X.-J., Xi, Y.-L., Zhu, X.-L., Lu, Y., Zhou, Y., Yan, H.-Y., Wang, J., Yang, Z.-M., Hang, C., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102979
Newborn and juveniles exhibit distinct transcriptional and pathological profiles after brain injury
Aderibigbe, O., Thakore, A. D., Griffin, M. N., Wood, L. B., & Margulies, S. S. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115808
Pathogenic Mechanisms in Amyotrophic Lateral Sclerosis
Held, A., & Petrozziello, T. (2026) · Springer eBooks · doi:10.1007/978-3-032-21135-4_25
BindingDB Entry 50022108: Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies.
BindingDB (2025) · UC San Diego · doi:10.7270/q21g0rxz
(2)生合成と代謝( バイオファクター研究のブレークスルー : 「ユビキノン(コエンザイムQ)」)
哲也, 中. (2001) · ビタミン · doi:10.20632/vso.75.5-6_273

Authors: Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F.
Affiliations: Harvard University (US)
ORCID: Matthews, Russell T.
Browne, Susan
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1998-07-21
Volume: 95
Issue: 15
Pages: 8892-8897
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.95.15.8892
PMC: PMC21173
OpenAlex: W2100454943
Cited by: 557
References: 49
Citations by year: 2026: 4 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 24 · 2020: 26 · 2019: 18 · 2018: 15 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 19 · 2013: 22 · 2012: 20
FWCI: 6.87
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p01ns031579-05)
National Institute on Aging (P01 AG 12992, P01AG012992)
National Institute of Neurological Disorders and Stroke (NS 16367, NS31579, P50NS016367)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords: coenzyme Q10, cerebral cortex, neuroprotection, 3-nitropropionic acid, striatal lesions, amyotrophic lateral sclerosis, transgenic mouse model, lifespan, neurodegenerative diseases, electron transport chain, free radical scavenging, oral administration
MeSH terms: Administration, Oral, Animals, Brain, Coenzymes, Humans, Male, Mice, Transgenic, Mitochondria, Rats, Inbred F344, Superoxide Dismutase, Ubiquinone, Rats, Sprague-Dawley, Neuroprotective Agents, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Coenzyme Q 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks